Journal
CELL REPORTS MEDICINE
Volume 4, Issue 1, Pages -Publisher
CELL PRESS
DOI: 10.1016/j.xcrm.2022.100910
Keywords
-
Categories
Ask authors/readers for more resources
The SARS-CoV-2 Omicron BA.4 and BA.5 variants caused major waves of infections. BA.4 shows high-level neutralization resistance regardless of the infecting variant, but can still be neutralized by antibodies from previous infections or vaccination breakthrough infections caused by Delta or BA.1. The reduced sensitivity of ADCC against BA.4 may contribute to observed protection from severe disease.
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Omicron BA.4 and BA.5 variants caused major waves of infections. Here, we assess the sensitivity of BA.4 to binding, neutralization, and antibody -dependent cellular cytotoxicity (ADCC) potential, measured by FcgRIIIa signaling, in convalescent donors infected with four previous variants of SARS-CoV-2, as well as in post-vaccination breakthrough infections (BTIs) caused by Delta or BA.1. We confirm that BA.4 shows high-level neutralization resistance regardless of the infecting variant. However, BTIs retain activity against BA.4, albeit at reduced titers. BA.4 sensitivity to ADCC is reduced compared with other variants but with smaller fold losses compared with neutralization and similar patterns of cross-reactivity. Overall, the high neutralization resistance of BA.4, even to antibodies from BA.1 infection, provides an immunological mechanism for the rapid spread of BA.4 immediately after a BA.1-dominated wave. Furthermore, although ADCC potential against BA.4 is reduced, residual activity may contribute to observed protection from severe disease.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available